The Cogstate Blog

Expert perspectives on improving cognitive measures from clinical trials to clinical practice.

Measuring Cognition in Pediatric Oncology Trials: Topics, Trends and Key Takeaways from the Children’s Oncology Group (COG) Fall Meeting

October 11, 2018

Data from Brain Health Registry show utility of online unsupervised cognitive testing using the Cogstate Brief Battery in older adults

August 10, 2018

Research efforts for therapies that slow or prevent AD involve large clinical trials that require participants who have the disease but who are experiencing only very early signs of cognitive decline. To find optimal study candidates, large pools of potential participants need to be screened in the most efficient way possible. The use of online health registries shows great promise for addressing this important need.

Trial Design of PCSK9-inhibitor, Evolocumab, in Pediatric Patients with Heterozygous Familial Hypercholesterolemia

June 18, 2018

Prof. Paul Maruff discusses a published paper detailing the design of a study investigating the PCSK9-inhibitor, evolocumab, in pediatric patients with heterozygous familial hypercholesterolemia.

Structured Exercise Program Improves Cognitive Functioning for Patients with First-Episode Psychosis

June 6, 2018

Swedish and Australian researchers published the effects of an organized exercise program on a group of adults diagnosed with first-episode psychosis. Results from the Cogstate Brief Battery showed a positive relationship between exercise and the cognitive functioning of these patients.

Study Shows Similar Symptom Profile in Ketamine Dependence with Persistent Psychosis and Schizophrenia

March 28, 2018

Researchers measured psychosis (PANSS) and cognitive impairments (Cogstate), and the symptom profile of persisting psychosis due to chronic heavy ketamine abuse resembled that of schizophrenia.

Studies Show Healthy Lifestyle Program Can Slow Cognitive Decline

February 11, 2018

Results from the neuropsychological test battery showed no difference between APOE ε4 allele carriers and the non-carriers, suggesting that a healthy lifestyle can slow cognitive decline, even for those with the genetic risk.

Strategic Central Monitoring of Psychometric Tests and Rating Scales

January 17, 2018

Even when employing the most intensive rater training program, many raters may still make errors in administering and scoring some psychometric tests and rating scales in clinical trials. Central Monitoring helps ensure the highest possible data quality through rigorous expert review.

Stay Hydrated Throughout The Day For Better Cognitive Performance

January 10, 2018

Research shows that drinking the appropriate amount of water improves cognitive performance, as seen from results on Cogstate computerized cognitive tests.

Key Advantages of Computerized Cognitive Testing in Clinical Trials

December 6, 2017

Cogstate computerized cognitive tests have been designed and validated to withstand the numerous operational challenges of conducting clinical trials — dramatically increasing the sensitivity and specificity of the measurement of cognition in clinical research.

Cogstate Participation at CTAD 2017

November 20, 2017

Cogstate CSO, Prof. Paul Maruff, discusses the recent Clinical Trials in Alzheimer’s Disease (CTAD) conference and the exciting scientific contributions from Cogstate.

1 2 3

How can we help you optimize the measurement of brain health?

Please fill out the form to get in touch